Company Overview
Gem Aromatics Limited manufactures and sells specialty ingredients in India, the United States, China, Brazil, Singapore, and internationally. The company offers mint and mint derivatives, such as peppermint, spearmint, and menthol; clove and clove derivatives, including clove oil, and eugenol and eugenol derivatives; phenol comprising anethole; and other ingredients, such as eucalyptus and eucalyptol, lemongrass, and other products for use in oral care, cosmetics, personal care, and other applications. The company was incorporated in 1997 and is headquartered in Mumbai, India.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.34.
Recent Developments
- Mar 2026 Revenue of ₹363.08 Cr (-26.6% YoY); net profit ₹1.43 Cr.
- Trailing 12 Months Year-on-year growth — revenue -45.4%, earnings -96.8%.
- 5-Year Trend Long-term compounding — revenue CAGR -4.6%, profit CAGR -68.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -4.63% |
| 1 Year: | -45.40% |
Compounded Profit Growth
| 5 Years: | -68.29% |
| 1 Year: | -96.80% |
Stock Price Performance
| 1 Year: | -42.68% |
| 6 Months: | +12.56% |
| 3 Months: | +10.12% |
| 1 Month: | -5.75% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross5d ago
- RSI (14)47.98 · Neutral
P/E of 653.11 is above the sector median of 25.90 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 653.1.
- Revenue declined at -4.6% CAGR over 5 years.
- Earnings shrank at -68.3% CAGR over 5 years.
- Trading 42.7% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GEMAROMA GEM AROMATICS LIMITED NSEINFRA | 182.87 | 653.11 | ₹955.26 Cr | 0.00% | 3.72% | 0.39% | -4.63% | -68.29% |
| 2 | AMBUJACEM Ambuja Cements Limited NSEINFRA | 436.50 | 24.45 | ₹1.08 L Cr | 0.45% | 4.60% | 7.97% | 8.86% | 34.61% |
| 3 | APLAPOLLO APL Apollo Tubes Limited NIFTY_MIDNSEINFRA | 1,945.00 | 43.97 | ₹54,004.56 Cr | 0.30% | 28.21% | 22.71% | 12.61% | 23.30% |
| 4 | ACUTAAS Acutaas Chemicals Limited NIFTY_SMALLNSEINFRA | 3,260.60 | 91.98 | ₹26,694.90 Cr | 0.05% | 16.51% | 21.52% | 24.34% | 30.18% |
| 5 | AETHER Aether Industries Limited NSEINFRA | 1,584.40 | 89.01 | ₹21,026.98 Cr | 0.00% | 12.15% | 8.94% | 21.23% | 18.94% |
| 6 | AARTIIND Aarti Industries Limited NIFTY_SMALLNSEINFRA | 501.20 | 34.33 | ₹18,179.86 Cr | 0.21% | 8.53% | 7.04% | 8.47% | -8.40% |
| 7 | ANURAS Anupam Rasayan India Ltd NIFTY_SMALLNSEINFRA | 1,213.00 | 78.51 | ₹13,809.80 Cr | 0.12% | 8.66% | 5.76% | 10.10% | -15.03% |
| 8 | ALKYLAMINE Alkyl Amines Chemicals Limited NSEINFRA | 1,921.90 | 54.58 | ₹9,829.78 Cr | 0.76% | 14.54% | 11.74% | -3.01% | -7.67% |
| 9 | ASHAPURMIN Ashapura Minechem Limited NSEINFRA | 729.10 | 17.36 | ₹6,964.81 Cr | 0.14% | 15.10% | 29.05% | 42.85% | 50.82% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 96.84 Cr | 202.22 Cr | 89.53 Cr | 78.90 Cr | 110.41 Cr |
| Cost of Revenue | 71.83 Cr | 147.88 Cr | 76.95 Cr | 60.73 Cr | 76.69 Cr |
| Gross Profit | 25.01 Cr | 54.33 Cr | 12.58 Cr | 18.17 Cr | 33.72 Cr |
| Operating Expenses | 13.88 Cr | 10.38 Cr | 12.58 Cr | 19.87 Cr | 27.02 Cr |
| Operating Income | 11.13 Cr | 43.96 Cr | -50,000 | -1.70 Cr | 6.70 Cr |
| EBITDA | 13.53 Cr | 45.44 Cr | 4.03 Cr | 5.36 Cr | 16.01 Cr |
| Interest Expense | 2.22 Cr | 3.44 Cr | 3.50 Cr | 2.58 Cr | 2.97 Cr |
| Pretax Income | 9.41 Cr | 40.08 Cr | -2.52 Cr | -5.93 Cr | 4.03 Cr |
| Tax Provision | 1.96 Cr | 12.47 Cr | 6.10 L | -94.00 L | 3.02 Cr |
| Net Income | 7.46 Cr | 27.60 Cr | -2.58 Cr | -4.99 Cr | 1.01 Cr |
| Diluted EPS | 1.43 | 5.28 | -0.04 | -1.04 | 0.19 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 418.61 Cr | 446.39 Cr | 494.92 Cr | 363.08 Cr |
| Cost of Revenue | 321.74 Cr | 345.12 Cr | 383.18 Cr | 279.32 Cr |
| Gross Profit | 96.87 Cr | 101.27 Cr | 111.75 Cr | 83.76 Cr |
| Operating Expenses | 30.00 Cr | 29.05 Cr | 30.59 Cr | 59.99 Cr |
| Operating Income | 66.87 Cr | 72.21 Cr | 81.15 Cr | 23.77 Cr |
| EBITDA | 65.92 Cr | 79.94 Cr | 89.61 Cr | 40.21 Cr |
| Interest Expense | 5.07 Cr | 6.08 Cr | 7.88 Cr | 11.26 Cr |
| Pretax Income | 56.09 Cr | 67.59 Cr | 74.38 Cr | 6.36 Cr |
| Tax Provision | 11.42 Cr | 17.49 Cr | 21.00 Cr | 4.94 Cr |
| Net Income | 44.67 Cr | 50.10 Cr | 53.38 Cr | 1.43 Cr |
| Diluted EPS | 8.55 | 9.59 | 10.22 | 0.28 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 295.76 Cr | 368.57 Cr | 536.41 Cr | 641.89 Cr |
| Current Assets | - | 244.37 Cr | 280.46 Cr | 344.11 Cr | 364.14 Cr |
| Cash & Equivalents | - | 10.57 Cr | 15.88 Cr | 3.03 Cr | 8.15 Cr |
| Inventory | - | 142.51 Cr | 174.48 Cr | 166.12 Cr | 233.70 Cr |
| Receivables | - | 79.64 Cr | 45.33 Cr | 140.99 Cr | 76.68 Cr |
| Total Liabilities | - | 116.23 Cr | 138.02 Cr | 252.43 Cr | 191.95 Cr |
| Current Liabilities | - | 115.46 Cr | 113.74 Cr | 181.69 Cr | 168.47 Cr |
| Long Term Debt | - | 28.30 L | 23.99 Cr | 68.68 Cr | 21.71 Cr |
| Total Debt | - | 90.20 Cr | 111.90 Cr | 226.75 Cr | 151.85 Cr |
| Total Equity | - | 179.53 Cr | 230.55 Cr | 283.98 Cr | 449.93 Cr |
| Shares Outstanding | - | 5.22 Cr | 5.22 Cr | 5.22 Cr | 5.22 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 15.30 Cr | 40.13 Cr | -24.92 Cr | 29.60 Cr |
| Investing Cash Flow | - | -14.36 Cr | -51.05 Cr | -92.54 Cr | -101.49 Cr |
| Financing Cash Flow | - | 6.44 Cr | 15.36 Cr | 104.53 Cr | 77.59 Cr |
| Capital Expenditure | - | -14.38 Cr | -39.14 Cr | -105.09 Cr | -95.11 Cr |
| Free Cash Flow | - | 92.50 L | 98.90 L | -130.00 Cr | -65.51 Cr |
| Net Change in Cash | - | 7.38 Cr | 4.44 Cr | -12.92 Cr | 5.71 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Gross Margin % | 23.1% | 22.7% | 22.6% | 23.1% |
| Operating Margin % | 16.0% | 16.2% | 16.4% | 6.5% |
| Net Margin % | 10.7% | 11.2% | 10.8% | 0.4% |
| ROE % | 24.9% | 21.7% | 18.8% | 0.3% |
| ROCE % | 37.1% | 28.3% | 22.9% | 5.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GEMAROMA
Should Weakness in Gem Aromatics Limited's (NSE:GEMAROMA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxPVDM5R21zd1ktV1R3bnZYWDJqU0JhMjd0Z2FQU3JfbURnMm9Cd3Vsa3pRVHRsMlZmcWVFU3BpM2NTODladGRrVVVOWGhBaGFLbW41aEJLVGhscW0tTjlwTWFMbnVMY01vMzVDeVJfUUNJelJRYWMzckpwYXJJbVJNSU1NenFxT3BnN2pPMU…
Gem Aromatics' (NSE:GEMAROMA) Shareholders Have More To Worry About Than Only Soft Earnings - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxPZnNLSS1tb2NnUEJjNGU3SjlibktqTS1TcE54dm95Vk1IN0c3MllOWDRTaUhrdFpPN1RJUHBlVFJjQ3lsUTZVeW1kdHEzOFFncE5lalVOUGZ3OE5lZzNPM3RKbGpWekJVZ01RRUdxY1VpdkNnYlVUQ0JmZ3hpVy1KUnBESFppNWFfaFliME…
Gem Aromatics Lists at ₹333, Gains 2.85% Over IPO Price - HDFC Sky
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNZTFEU1k1aFhHRjhlV2V0eFlVeklMV182QThqUHFfY0h0TmFSeUpuZDdqcjhrcWthLTZGSXVHR0lEODRadVEyRkx6TlNta1RNZ1N5Q1I5UGhITDhXTzJpUzN1RDd3Nmw3amxhLXRHZGVxXzRCeXFVMFhmOVpXRnVLLWdaenAyMExNeWM3bl…
Subdued Growth No Barrier To Gem Aromatics Limited (NSE:GEMAROMA) With Shares Advancing 25% - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxPTnVwbFp2aTF6djRQTkxtV2dGWEJnMUtBVzY1d21POEpqRVF0NlBUSk9VcXBKRWdoTm9NLU40WFVEMGdZcUplOTVfcEZGclk2Y0puY3BFNlY5aENnVnNPSS05MDNRUURqY0JCX2xMTV9tN3I2NmJYQjF6OTAxbDl3aU9DWERqSFRqUDhfWW…
Gem Aromatics Ltd Results 2025: Gem Aromatics Ltd Q4 Results & Revenue - INDmoney
<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE9ZdTVyS2RLZUZjRndQZzZtMHNJamI0YUxsTW5NRnRRR3BGbTJzNV9wRURDVU5ORmZ5SmF5YWVNc1g5ajNPelVlcEMxS25ZTHpoQU1XT205clZzZzVqRXF4SnJIRjJJcWxobDBVTEFTbXRBRFVkMWRsMg?oc=5" target="_blank">Gem A…
Gem Aromatics shares drop 3% to close below IPO price on market debut day - Moneycontrol.com
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOUmN4TGVXR3p3Q2k0OXplemZVYjJCdVNiOV9mY1NPRjdBR2xNSk1mLWh2NkJkLUlsdUx4N3o1c0cyVHp5NXEyOTRxeVBlczU5YjJzWG5fT1N5WERETjVBWXpHY2d0RUdtV3dtcVpkdkdEcEcwQ0FOeVpMT1pQMjFNU2I5ZFZoaGxEV2dqM2…
GEMAROMA — Frequently Asked Questions
What is the current share price of GEM AROMATICS LIMITED (GEMAROMA)?
As of 2026-08-07 06:31 IST, GEM AROMATICS LIMITED (GEMAROMA) trades at ₹182.87 on NSE. Its 52-week range is ₹134.63 to ₹319.05.
What is the market capitalisation of GEMAROMA?
GEM AROMATICS LIMITED (GEMAROMA) has a market capitalisation of ₹955.26 Cr on NSE.
What is the P/E ratio of GEMAROMA?
GEMAROMA trades at a trailing price-to-earnings (P/E) ratio of 653.11. The industry average P/E is 25.90. Its price-to-book (P/B) ratio is 2.12.
What is the return on equity (ROE) of GEMAROMA?
GEMAROMA has a return on equity (ROE) of 0.39%. Its return on capital employed (ROCE) is 3.72%.
Is GEMAROMA a good stock to buy?
This page provides a data-driven analysis of GEM AROMATICS LIMITED (GEMAROMA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.